Menu Search
Equities

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6990:HKG.HS

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Actions
  • Price (HKD)423.40
  • Today's Change0.00 / 0.00%
  • Shares traded316.60k
  • 1 Year change+138.13%
  • Beta--
Data delayed at least 15 minutes, as of Feb 12 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of drugs. The Company is mainly engaged in the research and development, manufacturing and commercialization of novel drugs in oncology, immunology and other therapeutic areas. The Company's products are antibody drug conjugates (ADCs) SKB264, A166 and others. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancer and other diseases.

  • Revenue in HKD (TTM)1.70bn
  • Net income in HKD-817.92m
  • Incorporated2016
  • Employees1.87k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.